TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 142 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $714,000 | +73.3% | 40,677 | -4.1% | 0.02% | +42.9% |
| Q2 2021 | $412,000 | +6766.7% | 42,423 | +111.6% | 0.01% | +1300.0% |
| Q3 2019 | $6,000 | -14.3% | 20,044 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $7,000 | -46.2% | 20,044 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $13,000 | -61.8% | 20,044 | 0.0% | 0.00% | -80.0% |
| Q4 2018 | $34,000 | -70.9% | 20,044 | -0.4% | 0.01% | -58.3% |
| Q3 2018 | $117,000 | – | 20,125 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |